Anal cancer
Results
Phase 2
This trial compared cisplatin and 5 fluorouracil (5FU) with carboplatin and paclitaxel for anal cancer. It was for people whose cancer has spread or come back after treatment, and who couldn’t have surgery. It was supported by Cancer Research UK.
This trial was open for people to join between 2013 and 2017, and the team reported the results in 2020.
Recruitment start: 19 December 2013
Recruitment end: 15 November 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sheela Rao
Australian Gastro-Intestinal Trials Group (AGITG)
Cancer Research UK
ECOG-ACRIN Cancer Research Group
Experimental Cancer Medicine Centre (ECMC)
International Rare Cancers Initiative (IRCI)
NHMRC Clinical Trials Centre (CTC)
NIHR Clinical Research Network: Cancer
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUK/12/038.
Last reviewed: 4 November 2020
CRUK internal database number: 10516
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
